Opens in a new tab

HEIDELBERG 

24-30 Sep |

Book your meeting

Predict response across alternative cancer therapies

One patient. Multiple possible outcomes.

Using multimodal patient data to model how the same patient may respond to different treatments.

See our research

For which patients can a new therapy improve outcomes?

STANDARD CARE
Tumor persists
AI: +6 months
NEW THERAPY
Complete response
AI: +6 months

Same patient, different therapies.

SUPPORTED BY
  • STARTING WITH BREAST CANCER - WE NEED TO CHANGE THESE STATISTICS

    Hundreds of thousands of patients are waiting on clinical uptake of new therapies

    Even 10% faster clinical uptake has a massive impact

    +0 patients

    could be treated earlier with 10% faster access

    +0 survivors

    with 10% faster clinical uptake

    +0 years

    from approval to peak sales

    Cancer4D: Beyond standard of care 

    what WE can do

    Why not an LLM? Precision medicine requires reproducible predictions - with an LLM the same prompt give different results.

    Clinicians say the 4D GenAI technology is a seismic shift

    Fully embedded into existing research infrastucture, for curated data and feedback from 300 healthcare providers

    We trained Cancer4D with breast and brain images, and are extending our capabilities to lung and prostate

    Learn more for

    Healthcare providers, pharma companies and regulatory authorities

    Go to our pages with more information
    Article

    Regulatory innovation for 4D generative AI

    8. December 2025
    >> Read more
    Article

    Validation of oncology virtual Phase III trials

    10. December 2025
    >> Read more
    Article

    4D generative AI in regulatory terms for EMA

    11. December 2025
    >> Read more

    “As a young woman, the risks of breast and interval cancer can be worrying. However, knowing that Aileen Health enables radiologists to not only detect breast cancer but also evaluate future risks of interval cancer gives me peace of mind. The thorough approach to early detection and prevention helps me feel more confident and reassured about the health of my family, friends and myself.”

    Matilda Åboge Eriksson
    Woman

    “This is a wonderful product, especially for younger women in high risk groups, who wants to wait with medical procedures until the children are born.“

    Liza
    Patient advocate

    “It is a great relief for women to hear that there are no signs of cancer for the next 2 years. Especially for women with a family history of cancer.“

    Mary
    Breast radiologist

    TESTIMONIALS

    Ai:leen Health started from conversations with women

    Together with providers and pharma, we can make sure women stop dying from the disease.

    OUR TEAM

    Scientific, technical, and business

    Our team has decades of experience in AI and working with healthcare systems

    Contact us now

    Our next stops

    Meet us in person when we are on the road

     We’d love to meet you in person!

    1. {mb_event_from: d M, y} - {mb_event_to: d M, y}

      Amsterdam, Netherlands

      EMA SME Info day

    Get notified when we have more news

    Together, we can revolutionize healthcare. Subscribe to our updates and be the first to know when and where Ai:leen is available.

    Newsletter

    You are about to download our 2025 ESMO AI poster “Predicting solid-tumor behaviour over time with explainable gen AI for precision oncology”

    By submitting this form, you agree to our privacy policy